AVTX
Avalo Therapeutics Inc.
$18.91
+$0.24(+1.29%)
73
Overall
80
Value
66
Tech
--
Quality
Market Cap
$281.44M
Volume
140.67K
52W Range
$3.39 - $20.72
Target Price
$35.86
Company Overview
| Mkt Cap | $281.44M | Price | $18.91 |
| Volume | 140.67K | Change | +1.29% |
| P/E Ratio | -8.0 | Open | $18.57 |
| Revenue | $441.0K | Prev Close | $18.67 |
| Net Income | $-35.1M | 52W Range | $3.39 - $20.72 |
| Div Yield | N/A | Target | $35.86 |
| Overall | 73 | Value | 80 |
| Quality | -- | Technical | 66 |
No chart data available
Latest News
Avalo Completes Enrollment for Phase 2 LOTUS Trial
TipRanks Auto-Generated Newsdesk•24 days ago
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $18.91 | +1.3% | 140.67K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |